A Comparison of Home Health Utilization, Outcomes, and Cost Between Medicare Advantage and Traditional Medicare.


Journal

Medical care
ISSN: 1537-1948
Titre abrégé: Med Care
Pays: United States
ID NLM: 0230027

Informations de publication

Date de publication:
01 01 2022
Historique:
pubmed: 6 11 2021
medline: 21 12 2021
entrez: 5 11 2021
Statut: ppublish

Résumé

Home health use is rising rapidly in the United States as the population ages, the prevalence of chronic disease increases, and older Americans express their desire to age at home. Enrollment in Medicare Advantage (MA) plans rather than Traditional Medicare (TM) has grown as well, from 13% of total Medicare enrollment in 2004 to 39% in 2020. Despite these shifts, little is known about outcomes and costs following home health in MA as compared with TM. The objective of this study was to measure the association of MA enrollment with outcomes and costs for patients using home health. This was a retrospective cohort study. Patients enrolled in plans offered by 1 large, national MA organization and patients enrolled in TM, with at least 1 home health visit between January 1, 2017, and June 30, 2018. MA enrollment. We compared the intensity of home health services and types of care delivered. The main outcome measures were hospitalization, the proportion of days in the home, and total allowed costs during the 180-day period following the first qualifying home health visit during the study period. Among patients who used home health, our models demonstrated enrollment in MA was associated with 14%, and 6% decreased odds of 60- and 180-day hospitalization, respectively, a 12.8% and 14.7% decrease in medical costs exclusive and inclusive of home health costs, respectively, and a 0.27% increase in the proportion of days at home during the 180-day follow-up, equivalent to an additional half-day at home. There were few differences in home health care delivered for MA and TM [mean number of visits in the first episode of care (17.1 vs. 17.3) and mean visits per week (3.2 vs. 3.3)]. The mean number of visits by visit type and percent of patients with each type was similar between MA and TM as well. Compared with enrollment in TM, enrollment in MA was associated with improved patient-centered outcomes and lower cost and utilization, despite few differences in the way home health was delivered. These findings might be explained by structural components of MA that encourage better care management, but further investigation is needed to clarify the mechanisms by which MA enrollment may lead to higher value home health care.

Sections du résumé

BACKGROUND
Home health use is rising rapidly in the United States as the population ages, the prevalence of chronic disease increases, and older Americans express their desire to age at home. Enrollment in Medicare Advantage (MA) plans rather than Traditional Medicare (TM) has grown as well, from 13% of total Medicare enrollment in 2004 to 39% in 2020. Despite these shifts, little is known about outcomes and costs following home health in MA as compared with TM.
OBJECTIVE
The objective of this study was to measure the association of MA enrollment with outcomes and costs for patients using home health.
DESIGN
This was a retrospective cohort study.
PARTICIPANTS
Patients enrolled in plans offered by 1 large, national MA organization and patients enrolled in TM, with at least 1 home health visit between January 1, 2017, and June 30, 2018.
EXPOSURE
MA enrollment.
MAIN MEASURES
We compared the intensity of home health services and types of care delivered. The main outcome measures were hospitalization, the proportion of days in the home, and total allowed costs during the 180-day period following the first qualifying home health visit during the study period.
KEY RESULTS
Among patients who used home health, our models demonstrated enrollment in MA was associated with 14%, and 6% decreased odds of 60- and 180-day hospitalization, respectively, a 12.8% and 14.7% decrease in medical costs exclusive and inclusive of home health costs, respectively, and a 0.27% increase in the proportion of days at home during the 180-day follow-up, equivalent to an additional half-day at home. There were few differences in home health care delivered for MA and TM [mean number of visits in the first episode of care (17.1 vs. 17.3) and mean visits per week (3.2 vs. 3.3)]. The mean number of visits by visit type and percent of patients with each type was similar between MA and TM as well.
CONCLUSIONS
Compared with enrollment in TM, enrollment in MA was associated with improved patient-centered outcomes and lower cost and utilization, despite few differences in the way home health was delivered. These findings might be explained by structural components of MA that encourage better care management, but further investigation is needed to clarify the mechanisms by which MA enrollment may lead to higher value home health care.

Identifiants

pubmed: 34739413
doi: 10.1097/MLR.0000000000001661
pii: 00005650-202201000-00010
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

66-74

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Knickman JR, Snell EK. The 2030 problem: caring for aging baby boomers. Health Serv Res. 2002;37:849–884.
Robison J, Shugrue N, Fortinsky RH, et al. Long-term supports and services planning for the future: implications from a statewide survey of Baby Boomers and older adults. Gerontologist. 2014;54:297–313.
Kasper JD, Wolff JL, Skehan M. Care arrangements of older adults: what they prefer, what they have, and implications for quality of life. Gerontologist. 2019;59:845–855.
Binette J, Vasold K. 2018 Home and Community Preferences: A National Survey of Adults Ages 18-Plus. American Association of Retired Persons; 2019. Available at: www.aarp.org/research/topics/community/info-2018/2018-home-community-preference.html . Accessed October 16, 2020.
Maliakkal AV, Sun AZ. Home care program reduces hospital readmissions in patients with congestive heart failure and improves other associated indicators of health. Home Health Care Manag Pract. 2014;26:191–197.
Leppin AL, Gionfriddo MR, Kessler M, et al. Preventing 30-day hospital readmissions: a systematic review and meta-analysis of randomized trials. JAMA Intern Med. 2014;174:1095–1107.
Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19). Older adults; 2020. Available at: www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/older-adults.html . Accessed October 22, 2020.
Report to Congress: Medicare Payment Policy. Chapter 9: Home health care services; 2019. Available at: www.medpac.gov/docs/default-source/reports/mar19_medpac_ch9_sec.pdf . Accessed October 16, 2020.
Cordier T, Slabaugh SL, Havens E, et al. A health plan’s investigation of healthy days and chronic conditions. Am J Manag Care. 2017;23:e323–e330.
Keehan SP, Cuckler GA, Poisal JA, et al. National Health Expenditure Projections, 2019–28: expected rebound in prices drives rising spending growth. Health Aff (Millwood). 2020;39:704–714.
Freed M, Damico A, Neuman T. A Dozen Facts About Medicare Advantage in 2020. San Francisco: Kaiser Family Foundation; 2021.
Skopec L, Huckfeldt PJ, Wissoker D, et al. Home health and postacute care use in Medicare Advantage and Traditional Medicare. Health Aff (Millwood). 2020;39:837–842.
Huckfeldt PJ, Escarce JJ, Rabideau B, et al. Less intense postacute care, better outcomes for enrollees in Medicare Advantage than those in fee-for-service. Health Aff (Millwood). 2017;36:91–100.
Timbie JW, Bogart A, Damberg CL, et al. Medicare Advantage and fee-for-service performance on clinical quality and patient experience measures: comparisons from three large states. Health Serv Res. 2017;52:2038–2060.
Powers BW, Yan J, Zhu J, et al. The beneficial effects of Medicare Advantage special needs plans for patients with end-stage renal disease. Health Aff. 2020;39:1486–1494.
Park S, White L, Fishman P, et al. Health care utilization, care satisfaction, and health status for Medicare Advantage and Traditional Medicare Beneficiaries with and without alzheimer disease and related dementias. JAMA Netw Open. 2020;3:e201809.
Waxman DA, Min L, Setodji CM, et al. Does Medicare Advantage enrollment affect home healthcare use? Am J Manag Care. 2016;22:714–720.
Skopec L, Zuckerman S, Aarons J, et al. Home health use in Medicare Advantage compared to use in Traditional Medicare. Health Aff (Millwood). 2020;39:1072–1079.
Thomas KS, Schwartz ML, Boyd E, et al. home health use following a cancer diagnosis among patients enrolled in Medicare Advantage and Traditional Medicare: findings from the newly linked SEER-Medicare and Home Health OASIS Data. J Natl Cancer Inst Monogr. 2020;2020:53–59.
Koppel R. Two wrongs do not make a right: flaws in alternatives to fee-for-service payment plans do not mean fee-for-service is a good solution to rising prices Comment on “Fee-for-Service Payment—An Evil Practice That Must Be Stamped Out?”. Int J Health Policy Manag. 2015;4:611–612.
Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130–1139.
Kim DH, Glynn RJ, Avorn J, et al. Validation of a claims-based frailty index against physical performance and adverse health outcomes in the Health and Retirement Study. J Gerontol A Biol Sci Med Sci. 2019;74:1271–1276.
Centers for Medicare and Medicaid Services. Home Health PPS; 2019. Available at: www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/HomeHealthPPS/index?redirect=/HomeHealthPPS/01_overview.asp . Accessed October 22, 2020.
O’Connor M, Bowles KH, Feldman PH, et al. Frontloading and intensity of skilled home health visits: a state of the science. Home Health Care Serv Q. 2014;33:159–175.
Burke LG, Orav EJ, Zheng J, et al. Healthy days at home: a novel population-based outcome measure. Healthc (Amst). 2020;8:100378.
Van Houtven CH, Smith VA, Sperber NR, et al. Advancing the science of population-based measures of home-time. Healthc (Amst). 2020;8:100463.
Pandey A, Keshvani N, Vaughan-Sarrazin MS, et al. Evaluation of risk-adjusted home time after acute myocardial infarction as a novel hospital-level performance metric for Medicare Beneficiaries. Circulation. 2020;142:29–39.
Groff AC, Colla CH, Lee TH. Days spent at home—a patient-centered goal and outcome. N Engl J Med. 2016;375:1610–1612.
Lynn J, Brock J. Time at home as a quality measure. EClinicalMedicine. 2019;11:5–6.
Lee H, Shi SM, Kim DH. Home time as a patient-centered outcome in administrative claims data. J Am Geriatr Soc. 2019;67:347–351.
Gao J. P values—a chronic conundrum. BMC Med Res Methodol. 2020;20:167.
Meyers DJ, Trivedi AN, Mor V, et al. Comparison of the quality of hospitals that admit Medicare Advantage patients vs Traditional Medicare patients. JAMA Netw Open. 2020;3:e1919310.
Kumar A, Rahman M, Trivedi AN, et al. Comparing post-acute rehabilitation use, length of stay, and outcomes experienced by Medicare fee-for-service and Medicare Advantage beneficiaries with hip fracture in the United States: a secondary analysis of administrative data. PLoS Med. 2018;15:e1002592.
Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46:399–424.
Agency for Healthcare Research and Quality. Care management: implications for medical practice, health policy, and health services research. Rockville, MD: AHRQ; 2018. Available at: www.ahrq.gov/ncepcr/care/coordination/mgmt.html . Accessed October 22, 2020.
Agency for Healthcare Research and Quality. Care coordination; 2018. Available at: www.ahrq.gov/ncepcr/care/coordination.html . Accessed October 22, 2020.

Auteurs

Adrianne W Casebeer (AW)

Humana Healthcare Research.

David Ronning (D)

Humana Inc., Louisville, KY.

Richard Schwartz (R)

Humana Inc., Louisville, KY.

Charron Long (C)

Humana Healthcare Research.

Rituparna Bhattacharya (R)

Humana Healthcare Research.

Claudia Uribe (C)

Humana Healthcare Research.

Courtney R Brown (CR)

Humana Healthcare Research.

Joy Cameron (J)

Humana Inc., Louisville, KY.

Phil Painter (P)

Humana Inc., Louisville, KY.

Anup Sharma (A)

Humana Inc., Louisville, KY.

Sandy Spitale (S)

Humana Inc., Louisville, KY.

Brian Powers (B)

Humana Inc., Louisville, KY.

Chuck Stemple (C)

Humana Inc., Louisville, KY.

William Shrank (W)

Humana Inc., Louisville, KY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH